Get personalized support here
It is metabolized in the body to produce substances essential for healthy metabolic function, making it valuable for those aiming to manage weight and support cardiovascular health
Based on early human studies and animal research, GLP-1 agonists may affect: Reward-related eating behaviours by potentially modulating dopamine signalling in brain reward circuits Food cravings and hedonic eating (eating for pleasure rather than hunger) Impulsivity around food , possibly reducing the compulsive aspects of eating Satiety signalling , enhancing the feeling of fullness after meals Some patients using GLP-1 medications for diabetes or weight management report not just reduced appetite but also diminished preoccupation with food, fewer intrusive thoughts about eating, and reduced cravings for specific foods, particularly those high in fat and sugar
You have a body mass index of 27 or more with a weight-related complication, such as high blood pressure and high cholesterol
Our at-home process is simple, and we are with you every step of the way, so you can focus on doing the things you love
This depends on what you value most
